세계의 말 헬스케어 시장 - 산업규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 활동별, 유통채널별, 지역별 부문, 경쟁(2020-2030년)

Global Equine Healthcare Market was valued at USD 3.58 Billion in 2024 and is expected to reach USD 5.77 Billion in the forecast period with a CAGR of 8.26% through 2030. The Global Equine Healthcare Market is experiencing steady growth due to rising awareness about equine health management and increasing investments in veterinary care. The demand for preventive healthcare solutions, including vaccines, dewormers, and advanced diagnostic tools, is expanding as horse owners, breeders, and equestrian professionals prioritize animal welfare. The growing adoption of technologically advanced monitoring devices and wearable sensors for real-time health tracking has transformed equine healthcare practices. The industry is also witnessing a surge in specialized equine insurance policies, making advanced treatments more accessible. The emergence of equine rehabilitation centers and regenerative medicine therapies such as stem cell and platelet-rich plasma treatments is further contributing to market expansion.

The market is driven by advancements in veterinary pharmaceuticals, nutrition, and disease management solutions tailored for equine species. The increasing prevalence of equine diseases, including respiratory disorders, laminitis, and infectious conditions, is pushing the demand for innovative treatment options. Rising participation in equestrian sports and racing is fueling the need for performance monitoring, injury prevention, and orthopedic care. The adoption of digital health solutions, such as telemedicine and AI-based diagnostic platforms, is enhancing veterinary consultations and treatment efficiency. Government initiatives supporting equine disease control and biosecurity measures are also playing a crucial role in market growth.

The industry faces challenges related to the high costs associated with advanced equine medical treatments and limited access to specialized veterinary care in remote areas. Stringent regulations governing equine drug approvals and animal welfare policies impact the commercialization of new healthcare products. Concerns over counterfeit veterinary drugs and the need for improved diagnostic accuracy pose additional hurdles. Managing infectious disease outbreaks in equine populations remains a critical issue, requiring enhanced biosecurity measures and vaccination programs. The market presents opportunities for innovation in personalized equine nutrition, wearable health monitoring devices, and regenerative therapies, which are expected to drive long-term growth.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market.

As equestrian sports gain prominence, more people are investing in horse ownership. In the United States alone, the horse population was reported to be over 10.6 million in both 2020 and 2021, accounting for 18% of the world's equine population. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market.

The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care.

Key Market Challenges

High Cost of Specialized Care

The high cost of specialized care presents a significant challenge in the global equine healthcare market. Horses require extensive medical attention, including routine check-ups, vaccinations, dental care, and emergency treatments. When specialized care such as orthopedic surgeries, regenerative therapies, or advanced diagnostic imaging is needed, expenses rise considerably. Veterinary specialists trained in equine medicine often charge premium fees due to the complexity of procedures and the need for specialized equipment. Many horse owners struggle with these costs, especially those involved in non-commercial horse ownership or small-scale equestrian businesses.

Equine healthcare is further complicated by the need for ongoing treatments. Chronic conditions such as musculoskeletal disorders, respiratory issues, and metabolic diseases require long-term management, which leads to continuous financial burdens. Advanced treatments like stem cell therapy, laser therapy, and MRI scans can be prohibitively expensive, limiting access to necessary medical interventions. Insurance coverage for equine healthcare is not as widely available or comprehensive as human health insurance, making it difficult for owners to afford specialized care without significant out-of-pocket expenses.

The rising cost of equine healthcare has also impacted equestrian sports and breeding programs. Competitive horses require top-tier medical care to maintain performance and prevent injuries. When specialized care becomes unaffordable, it leads to compromised treatment quality, potential neglect, or premature retirement of horses from competitions. In breeding programs, high veterinary costs affect reproductive health management, including artificial insemination and embryo transfer services. Without affordable specialized care, the long-term sustainability of horse ownership and equine-related industries remains a challenge. Addressing these cost concerns through innovative financing options, insurance expansion, and technological advancements in affordable treatments is crucial for supporting the growth of the equine healthcare market.

Key Market Trends

Precision Medicine and Personalized Care

The global equine healthcare market is witnessing a shift toward precision medicine and personalized care, driven by advancements in veterinary diagnostics, genomics, and data-driven treatment approaches. Precision medicine focuses on tailoring healthcare solutions based on the specific genetic, physiological, and environmental factors of each horse. Veterinarians are leveraging genomic testing and biomarker analysis to develop individualized treatment plans, ensuring more effective disease management and preventive care. Genetic profiling enables early detection of predispositions to conditions such as laminitis, musculoskeletal disorders, and respiratory diseases, allowing for targeted interventions before clinical symptoms emerge. Personalized nutrition plans, based on metabolic profiling, are helping optimize horse health, performance, and longevity.

Wearable health-monitoring devices and telemedicine solutions are enhancing personalized care by continuously tracking vital parameters, including heart rate, temperature, and gait patterns. These real-time insights allow early detection of health abnormalities, reducing the risk of severe illnesses and costly medical interventions. Equine athletes benefit from customized rehabilitation programs, integrating physiotherapy, regenerative medicine, and laser therapy tailored to their specific recovery needs. The adoption of stem cell and gene therapy is further revolutionizing treatment strategies by offering regenerative solutions customized to the genetic makeup and condition of individual horses.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim GmbH
• Merck & Co., Inc.
• Hallmarq Veterinary Imaging Ltd
• Esaote SpA
• Vetoquinol SA
• IDEXX Laboratories, Inc.
• Dechra Pharmaceuticals PLC
• Arthrex Inc.
• Heska Corporation

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

• Vaccines
• Pharmaceuticals
• Medicinal Feed Additives
• Diagnostics
• Software & Services
• Others

Equine Healthcare Market, By Indication:

• Musculoskeletal Disorders
• Parasite Control
• Internal Medicine
• Equine Herpes Virus
• Equine Encephalomyelitis
• Equine Influenza
• West Nile Virus
• Tetanus
• Others

Equine Healthcare Market, By Activity:

• Sports/Racing
• Recreation
• Others

Equine Healthcare Market, By Distribution Channel:

• Veterinary Hospitals & Clinics
• E-commerce
• Others

Equine Healthcare Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
  • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
  • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Equine Healthcare Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Activity
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Healthcare Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Activity
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Equine Healthcare Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Activity
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Equine Healthcare Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Activity
      • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Activity
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Equine Healthcare Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Activity
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Equine Healthcare Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Activity
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Equine Healthcare Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Activity
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Equine Healthcare Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Activity
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Equine Healthcare Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Activity
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Activity
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Equine Healthcare Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Activity
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Equine Healthcare Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Activity
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Equine Healthcare Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Activity
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Equine Healthcare Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Activity
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Equine Healthcare Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Activity
      • 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Activity
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Healthcare Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Activity
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Equine Healthcare Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Activity
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Equine Healthcare Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Activity
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Activity
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Healthcare Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Activity
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Activity
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Equine Healthcare Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Activity
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Boehringer Ingelheim GmbH
• 14.3. Merck & Co., Inc.
• 14.4. Hallmarq Veterinary Imaging Ltd
• 14.5. Esaote SpA
• 14.6. Vetoquinol SA
• 14.7. IDEXX Laboratories, Inc.
• 14.8. Dechra Pharmaceuticals PLC
• 14.9. Arthrex Inc.
• 14.10. Heska Corporation

15. Strategic Recommendations

16. About Us & Disclaimer